Furthermore, THF utilization via the histidine degradation pathway and SIRT5-mediated desuccinylation of HINT1 were crucial for histidine combination therapy to ameliorate chemoresistance in B-ALL cells. Here, SIRT5 is linked to acute lymphoblastic leukemia.